arcoro SNAPS

Disruptive APDS technology for the treatment of dysglycaemia

Brittle diabetes is a special form that affects one in three out of every 1,000 insulin-dependent patients. Recurrent episodes of DKA and the resulting hospitalisation reduce the quality of life of these people enormously. Conventional diabetes treatments often do not achieve the desired results. A new innovative approach with a disruptive technology now promises to optimise the regulation of blood glucose levels and increase the time-in-range, which should improve the course of the disease and the quality of life of those affected and reduce constant hospital stays. See for yourself!

    * Pflichtfelder
    Your contact person

    Anne Plonz

    Business Analyst

    arcoro SNAPS

    Fused Deposition Modelling (FDM)

    Are you familiar with additive manufacturing processes in medical technology?

    SWIR microscopy

    Innovative technology for improved imaging

    3D printed medicines using ZipDose technology

    Manufacture and advantages of additively manufactured drugs.